先天性巨細胞病毒感染對於兒童聽損之影響:初報

Slides:



Advertisements
Similar presentations
Newborn Hearing Screening AAP Teleconference November 12, 2003.
Advertisements

Does UNHS Identify All Children with GJB2 (Connexin 26) Deafness? Presented by Wendy D. Hanks, Ph.D. Gallaudet University.
Karin M. Dent, MS, CGC John C. Carey, MD, MPH University of Utah
TM Early Hearing Detection and Intervention (EHDI) Centers for Disease Control and Prevention National Center on Birth Defects and Developmental Disabilities.
Saotharlann Náisiúnta Tagartha Viris UCD UCD National Virus Reference Laboratory Dr. Jeff Connell Assistant Director National Virus Reference Laboratory.
Department of Pediatrics Baylor College of Medicine and Texas Children’s Hospital, Houston, Texas Parental Experience: Diagnostic Dilemma with congenital.
III. Clinical Manifestations of Dengue and Dengue Hemorrhagic Fever CENTERS FOR DISEASE CONTROL AND PREVENTION.
Cytomegalovirus in Neonates David K. Hong, MD Pediatrics/Infectious Diseases & Immunology/Allergy Stanford University Medical School Santa Clara Valley.
A case series of ART-associated gynaecomastia reported to the National HIV & TB Healthcare Workers (HCW) hotline Christine Njuguna. Division of Clinical.
The need for screening newborns for congenital Cytomegalovirus referred in the Neonatal Hearing Screening Program F.A.J. Schornagel 1, M.J. Korndewal 1,
Early Hearing Detection and Intervention (EHDI) ~ Challenges and Opportunities ~
Alport Syndrome: Dealing with Hearing Loss and Advances in Technology
PATTERN OF HEARING LOSS IN SICKLE CELL DISEASE HAMAD AL-MUHAIMEED, M.D. Professor/Consultant ORL Department of ORL-H & NS King Abdul Aziz University Hospital.
Hearing Loss in Alport Syndrome Dr Sudhira Ratnayake Consultant in Audiovestibular Medicine Gem Centre Royal Wolverhampton NHS Trust 7/2/20151Alport Information.
Hear and now: Chinese Health in NZ
Hypothermia for Neonatal Hypoxic Ischemic Encephalopathy: An Updated Systematic Review and Meta-analysis Tagin MA, Woolcott CG, Vincer MJ, Whyte RK, Stinson.
1 Universal Immunization Against Rare Diseases  How much is a child’s life worth?  The individual vs society.
Chapter 1 Lecture 2 5/2/2015 Hearing disorders in children/ Hala AlOmari1.
Semiramis Zizlavsky Pre PITO 8, Sept 2,2013 Jakarta
Outcomes of preterm birth Stefan Johansson Department of Neonatology, Karolinska university hospital Department of Medical Epidemiology and Biostatistics,
  Three categories generally describe Hearing Loss:  Type of Hearing Loss  Degree of Hearing Loss  Configuration of Hearing Loss  It is important.
Risk Factors For Permanent Hearing Loss Betty Vohr, M.D. Medical Director Rhode Island Hearing Assessment Program Professor of Pediatrics Brown Medical.
Impact of Highly Active Antiretroviral Therapy on the Incidence of HIV- encephalopathy among perinatally- infected children and adolescents. Kunjal Patel,
EARLY CHILDHOOD OUTCOMES AT THE BOTSWANA- BAYLOR CHILDREN’S CLINICAL CENTRE OF EXCELLENCE: A REPORT TO THE WHO TECHNICAL REFERENCE GROUP ON PEDIATRIC CARE.
CMV +ve Control Introduction cCMV affects ~1% of all newborns born annually in the U.S. ~ 10% born with symptoms typically associated with cCMV Most develop.
Sensorineural H/L D efination hearing loss when the cause is Cochlea or Auditory nerve.
HEARING ASSESSMENT OF THE SCHOOL-AGE CHILD Ear Rounds October 1, 2009 Calma | Capili | Coruna | Dagang | Datukon | Dayrit | de Castro | de la Llana.
Changing Prevalence of Cerebral Palsy Coleen Boyle, Ph.D. National Center on Birth Defects and Developmental Disabilities Centers for Disease Control and.
Prevalence and Causes of Hearing Loss. Prevalence of Hearing Loss Each year in the United States, more than 12,000 babies are born with a hearing loss.
Hearing Testing Characteristics of a Hearing Loss Hearing Testing Middle Ear Measurement.
Introduction to Audiology How to Read an Audiogram Degrees of Hearing Loss Types, Causes and Prevalence of Hearing Loss Types of Tests.
CHAPTER 14 UNDERSTANDING STUDENTS WITH HEARING LOSS.
Chapter 14 Understanding Students with Hearing Loss.
Genetic examination for hearing loss and its clinical applications 8 th International Symposium of Rare Diseases 2014/9/19 Chen-Chi Wu, MD, PhD. Department.
Herpes Simplex Virus Type 2 infection among U.S. military service members: Public Health Implications and Opportunities for HIV Prevention Christian T.
Diagnostic and Rehabilitative Audiology Danielle Rose, Au.D. Clinical Audiologist Vanderbilt Bill Wilkerson Center.
Congenital CMV infection Infectious and Tropical Pediatric Division Department of Child Health Medical Faculty, University of Sumatera Utara.
Depression As a Predictor of Mortality and Hospitalization Among Hemodialysis Patients in the United States and Europe.
MUMPS MUMPS.
Newborn Screening for Congenital CMV? Opportunity for Innovation
Congenital Infections impact on newborns and infants
CMV infection in pregnancy Annual CARIS WALES meeting
Zika.
INTRODUCTION TO AUDIOLOGY (SPHS 1100)
Bridging the Gap from the Clinic to the Classroom
Copyright © American Speech-Language-Hearing Association
DISCHER J, ESTEVE-FRAYSSE MJ , CASPER C, BENARD M, CALMELS MN
BY MAELO DAVID BUMULA SC BUNGOMA COUNTY
Copyright © American Speech-Language-Hearing Association
Hearing Loss.
Copyright © American Speech-Language-Hearing Association
The Effect of Family Social Intervention on Treatment Response in Children with HIV Infection Francine Cheng DO, Janak Patel MD, Debbie Konopik SWA, and.
Sadegh jafarzadeh Ph.D Mashhad university of medical sciences
Hearing-targeted testing for early diagnosis of congenital CMV
Shan He, PhD Intermountain Healthcare
PAEDIATRIC AIDS ¨     Acquired immunodeficiency Syndrome (AIDS) is caused by Human Immunodeficiency Virus type 1 and 2 ¨     World wide problem, more.
UOG Journal Club: April 2017
Risk Factors for Late Onset Hearing Loss in Children
Korres S. et al; Athens, Greece
First Annual National EHDI Meeting
Are EHDI Systems Missing Children With Minimal Hearing Loss?
Enhanced Drug Delivery to the Inner Ear
CHAPTER 14: Understanding Children with Hearing Loss
Identifying Qualified Audiologists for Assessment of Babies
POPE-2 Trial design: Patients with moderate to large pericardial effusion after cardiac surgery were randomized to colchicine 2 mg loading dose, then 1.
Figure 2. Patient stratification by the reported duration of symptoms and disease severity at the time of assessment Patient stratification by the reported.
Proposed diagnostic and management algorithm for maternal and congenital CMV infection. Proposed diagnostic and management algorithm for maternal and congenital.
Neurological outcomes of congenital CMV infection.
Comparison of cytomegalovirus (CMV) load in urine samples of newborns with congenital CMV infection with respect to the changes in MRI findings. Comparison.
Presentation transcript:

先天性巨細胞病毒感染對於兒童聽損之影響:初報 羅大烜 吳振吉 許巍鐘 呂俊毅 劉殿楨 許權振 台大醫院耳鼻喉部

Introduction Sensorineural hearing loss (SNHL) is the most common sensory defect in children Among non-genetic causes of SNHL, congenital cytomegalovirus (cCMV) infection is the most prevalent1,2 cCMV infection accounts for 10-20% SNHL in children1,2

Congenital CMV infection (0.58-0.7% in industrialized contries) 2-4 ~1/10 ~9/10 Symptomatic Neonates Asymptomatic Neonates • IUGR • Microcephaly • Petechiae • Hepatosplenomegaly • Encephalitis • CNS defect (ex. SNHL)

Congenital CMV infection (0.58-0.7% in industrialized contries) 2-4 ~1/10 ~9/10 Symptomatic Neonates Asymptomatic Neonates 40-50% 13.5% Sequelae Sequelae Hearing loss: most common Congenital or progressive Bilateral or unilateral Treatable w/ antiviral mx

Patients cCMV infection N=35 Asymptomatic at birth N= 16 Passed NHS (2014 ~, NTUH) Asymptomatic at birth N= 16 Passed NHS N=16 Failed NHS N=0 N=12 N=5 No NHS data N=2 Symptomatic at birth N= 19 NHS: New born hearing screen

Patients cCMV infection N=35 Asymptomatic at birth N= 16 Passed NHS (2014 ~, NTUH) Asymptomatic at birth N= 16 Passed NHS N=16 Failed NHS N=0 N=12 N=5 No NHS data N=2 Symptomatic at birth N= 19 NHS: New born hearing screen

Assessments CMV viral load Audiologic assessments Blood serum viral load (cp/ml) Initial viral load: viral load tested within 1 m after birth Viral suppression: serum viral load reduced to undetectable Audiologic assessments AABR, DPOAEs, ABR, sound field, PTA Grades of hearing loss5 26-40dB Mild 41-70dB Moderate 71-90dB Severe >91dB Profound

Demographic data Characteristics N (%) Total 35 Male 24 69% Female 11 31% Passed NHS 21 60% Failed NHS 12 34% No NHS data 2 6% Asymptomatic 16 46% Symptomatic 19 54% HL 15 43% Unilateral HL 7 20% Bilateral HL 8 23% No HL No Hearing test data 1 3%

NHS or neonatal symptoms as predictors? 100 (12/12) 83.3 (15/18) 9.5 (2/21) 0 (0/16) p < 0.01 p < 0.01

Unilateral vs. Bilateral HL Bilateral 較嚴重? => no P>0.05

Initial viral load vs. Hearing features Initial viral load vs. NHS Initial viral load vs. HL p = 0.09 p = 0.07 Pass NHS Fail NHS Initial VL (cp/ml) No HL HL Initial VL (cp/ml) Boxplot of Initial VL and for NHS and HL. Box, defined by quartiles Q1 and Q3; bar, median; whiskers, lowest and highest value; o, outliers

Viral suppression and HL Serum viral load decreased gradually in most patients Most patients achieved serum viral suppression before 1 y (median = 4.5 m) Most patients showed stable hearing levels as the viral load decreased Some exceptions Throat/Urine VL suppression date?

Special case -1 Hearing loss deteriorated even after the viral load reached undetectable level

Special case -2 A case with immunodeficiency (Activated PI3K-delta syndrome) Focus 在後面

Conclusions Failing NHS or being symptomatic at birth are predictors of HL development in cCMV infection Severity of hearing loss was not different between uni- and bilateral cases Initial viral load was not significantly related to NHS or hearing loss development Hearing deterioration could occur even in cases with serum viral suppression

Thanks for attention!!

Reference Morton CC, Nance WE. Newborn hearing screening—a silent revolution. N Engl J Med 2006;354:2151-64. Goderis J, De Leenheer E, et al. Hearing loss and congenital CMV infection: a systematic review. Pediatrics 2014;134:972-82. Dollard SC, Grosse SD, et al. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 2007;17:355-63. Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus infection. Rev Med Virol 2007;17:253-76. Julie G., et al., Hearing in Children with Congenital Cytomegalovirus Infection:Results of a Longitudinal Study, J Pediatr 2016;172:110-5